Comera Life Sciences Holdings, Inc. (CMRA)

Market Cap	3.07K -100.0%
Revenue (ttm)	1.00M +81.8%
Net Income	-9.35M
EPS	-0.48
Shares Out	30.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,875
Average Volume	5,637
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0002
Beta	-78.42
RSI	35.25
Earnings Date	n/a

About CMRA

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 13
• Stock Exchange: OTCMKTS
• Ticker Symbol: CMRA

Financial Performance

In 2022, CMRA's revenue was $633,102, an increase of 97.95% compared to the previous year's $319,832. Losses were -$18.38 million, 237.1% more than in 2021.